Skip to main content
Log in

Safety and efficacy of external electrical cardioversion in patients with left ventricular leads

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Atrial arrhythmias lower the biventricular pacing percentage in cardiac resynchronization therapy (CRT) treated patients (pts) and have a high prevalence in this population. External electrical cardioversion (ECV) is commonly performed to restore sinus rhythm. There is a paucity of data on the safety and efficacy of ECV in pts with CRT devices.

Methods

Forty-three pts with CRT devices undergoing ECV at two centers were included prospectively. Devices were interrogated immediately prior to and after ECV, as well as after 4 weeks.

Results

Devices (CRT-D in 38 and CRT-P in 5) were all implanted in left pectoral position, with predominantly bipolar left ventricular (LV) leads. Sixty-one shocks were delivered, all biphasic. Arrhythmia had recurred in 36 % of pts at follow-up (FU). There was a significant increase in LV lead threshold voltage and drop in bipolar LV lead impedance after ECV, which returned to normal at FU. An at least twofold increase in pacing threshold voltage at FU was seen in 2 LV leads and a 0.5 V increase in threshold in 3 LV leads. Overall, biventricular pacing significantly increased during FU.

Conclusion

ECV in CRT pts was safe and effective in this two-center study. A transient increase in LV lead pacing threshold was observed. Relevant changes in pacing threshold at FU occurred in five LV leads—identification and regular FU of these pts are necessary. Restoring SR through ECV significantly increased the biventricular pacing percentage but arrhythmia recurrence was frequent. CRT pts with atrial arrhythmias require close FU after ECV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AF:

Atrial fibrillation

CRT:

Cardiac resynchronization therapy

ECV:

External electrical cardioversion

FU:

Follow-up

LV:

Left ventricular

TOE:

Transoesophageal echocardiography

References

  1. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338

    Article  PubMed  Google Scholar 

  2. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395

    Article  CAS  PubMed  Google Scholar 

  3. Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329

    Article  PubMed  Google Scholar 

  4. Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA (2009) Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100 % biventricular pacing necessary? J Am Coll Cardiol 53:355–360

    Article  PubMed  Google Scholar 

  5. Hayes DL, Boehmer JP, Day JD, Gilliam FR, Heidenreich PA, Seth M, Jones PW, Saxon LA (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469–1475

    Article  PubMed  Google Scholar 

  6. Cheng A, Landman SR, Stadler RW (2012) Reasons for loss of cardiac resynchronization therapy pacing: insights from 32,844 patients. Circ Arrhythm Electrophysiol 5:884–888

    Article  PubMed  Google Scholar 

  7. Ruwald AC, Pietrasik G, Goldenberg I, Kutyifa V, Daubert JP, Ruwald MH, Jons C, McNitt S, Wang P, Zareba W, Moss AJ (2014) The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter–defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol 63:1190–1197

    Article  PubMed  Google Scholar 

  8. Ousdigian KT, Borek PP, Koehler JL, Heywood JT, Ziegler PD, Wilkoff BL (2014) The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circ Arrhythm Electrophysiol 7:370–376

    Article  PubMed  Google Scholar 

  9. Lown B, Neuman J, Amarasingham R, Berkovits BV (1962) Comparison of alternating current with direct electroshock across the closed chest. Am J Cardiol 10:223–233

    Article  CAS  PubMed  Google Scholar 

  10. Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 33(21):2719–2747

    Article  PubMed  Google Scholar 

  11. January CT, Wann LS, Alpert JS, et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation

  12. Levine PA, Barold SS, Fletcher RD, Talbot P (1983) Adverse acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar cardiac pacing systems. J Am Coll Cardiol 1:1413–1422

    Article  CAS  PubMed  Google Scholar 

  13. Waller C, Callies F, Langenfeld H (2004) Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes Is external cardioversion contraindicated in patients with permanent pacing systems? Europace 6:165–168

    Article  PubMed  Google Scholar 

  14. Altamura G, Bianconi L, Lo Bianco F, Toscano S, Ammirati F, Pandozi C, Castro A, Cardinale M, Mennuni M, Santini M (1995) Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol 18:194–198

    Article  CAS  PubMed  Google Scholar 

  15. Manegold JC, Israel CW, Ehrlich JR, Duray G, Pajitnev D, Wegener FT, Hohnloser SH (2007) External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter–defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Eur Heart J 28:1731–1738

    Article  PubMed  Google Scholar 

  16. Tracy CM, Akhtar M, DiMarco JP, Heart Rhythm Society et al (2006) American College of Cardiology/American Heart Association 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation and cardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on clinical competence and training developed in collaboration with the Heart Rhythm Society. J Am Coll Cardiol 48:1503–1517

    Article  PubMed  Google Scholar 

  17. Israel CW, Nowak B, Willems S, Bänsch D, Butter C, Doll N, Eckardt L, Geller JC, Klingenheben T, Lewalter T (2011) Empfehlungen zur externen Kardioversion bei Patienten mit Herzschrittmacher oder implantiertem Kardioverter/Defibrillator. Der Kardiologe 5:257–263

    Article  Google Scholar 

  18. Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Böcker D, Breithardt G, Haverkamp W, Borggrefe M (2002) Anterior–posterior versus anterior–lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 360:1275–1279

    Article  PubMed  Google Scholar 

  19. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O’Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators (2008) Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677

    Article  CAS  PubMed  Google Scholar 

  20. Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T (2013) A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 61:1894–1903

    Article  PubMed  Google Scholar 

  21. Ganesan AN, Brooks AG, Roberts-Thomson KC, Lau DH, Kalman JM, Sanders P (2012) Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 59:719–726

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None of the authors have a conflict of interest to report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jakob Lüker.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lüker, J., von Bodman, G., Sultan, A. et al. Safety and efficacy of external electrical cardioversion in patients with left ventricular leads. Clin Res Cardiol 104, 439–445 (2015). https://doi.org/10.1007/s00392-014-0800-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-014-0800-5

Keywords

Navigation